These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36474216)

  • 1. Clinical manifestations and prognosis of unexpected uterine sarcoma of uterine fibroids in Tianjin China.
    Cheng G; Hu Y; Gong Y
    BMC Womens Health; 2022 Dec; 22(1):495. PubMed ID: 36474216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
    Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients.
    Cao H; Li L; Yang B; Luo G; Lou J; Xi M
    Cancer Manag Res; 2019; 11():7007-7014. PubMed ID: 31440089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
    Mettler L; Abdusattarova K; Alkatout I
    Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
    Cui RR; Wright JD
    Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.
    Ayhan A; Tunc M; Boran N; Khatib G; Gokcu M; Simsek T; Ozen OI; Toptas T; Yalcin I; Meydanli MM
    Arch Gynecol Obstet; 2021 Aug; 304(2):475-483. PubMed ID: 33392719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
    Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
    Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
    Chen Q; Shi H; Lu W; Lu B
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
    Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI features and clinical outcomes of unexpected uterine sarcomas in patients who underwent high-intensity focused ultrasound ablation for presumed uterine fibroids.
    Wang Q; Wu X; Zhu X; Wang J; Xu F; Lin Z; Gong C; He M; Zhang L
    Int J Hyperthermia; 2021 Sep; 38(2):39-45. PubMed ID: 34420442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
    Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
    Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma.
    Gao Z; Li L; Meng Y
    PLoS One; 2016; 11(2):e0148050. PubMed ID: 26828206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
    Chen I; Hopkins L; Firth B; Boucher J; Singh SS
    J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy.
    Hur HC; King LP; Klebanoff MJ; Hur C; Ricciotti HA
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():122-127. PubMed ID: 26520875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
    Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
    BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine morcellation and survival in uterine sarcomas.
    Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
    Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.